Therapeutic implications of sex differences in asthma and atopy

Mustafa Osman

    Research output: Contribution to journalArticle

    121 Citations (Scopus)

    Abstract

    Clear sex differences exist in asthma and atopy with a preponderance of boys before puberty. There is a reversal of this sex ratio during puberty with girls having more asthma and atopy throughout the reproductive years. Elucidating the reasons for the switch in the sex ratio should provide fresh insights into asthma and atopy with a real prospect of novel therapies for these troublesome diseases. The challenge is to match the epidemiology and physiology with the accumulating scientific knowledge on gender differences in immune responses. Hormonal changes have been implicated in the reversal of the sex ratio. Testosterone is an immunosuppressant and is likely to be protective, while female sex steroids are proinflammatory and will increase the susceptibility to atopy. Modified so as to be non-virilising/feminising, sex steroids could therefore play a useful part in modulating the immunological and inflammatory processes that underlie asthma and other allergic disorders, complementing the currently used glucocorticoid derived steroids.

    Original languageEnglish
    Pages (from-to)587-590
    Number of pages3
    JournalArchives of Disease in Childhood
    Volume88
    Issue number7
    DOIs
    Publication statusPublished - 2003

    Keywords

    • SYSTEMIC LUPUS-ERYTHEMATOSUS
    • PEAK FLOW VARIABILITY
    • MENSTRUAL-CYCLE
    • IMMUNE-SYSTEM
    • RESPIRATORY SYMPTOMS
    • RHEUMATOID-ARTHRITIS
    • GENDER DIFFERENCES
    • RISK-FACTORS
    • LUNG GROWTH
    • T-CELLS

    Cite this

    Therapeutic implications of sex differences in asthma and atopy. / Osman, Mustafa.

    In: Archives of Disease in Childhood, Vol. 88, No. 7, 2003, p. 587-590.

    Research output: Contribution to journalArticle

    @article{ee7612e1e7384b308a0de98369beaf11,
    title = "Therapeutic implications of sex differences in asthma and atopy",
    abstract = "Clear sex differences exist in asthma and atopy with a preponderance of boys before puberty. There is a reversal of this sex ratio during puberty with girls having more asthma and atopy throughout the reproductive years. Elucidating the reasons for the switch in the sex ratio should provide fresh insights into asthma and atopy with a real prospect of novel therapies for these troublesome diseases. The challenge is to match the epidemiology and physiology with the accumulating scientific knowledge on gender differences in immune responses. Hormonal changes have been implicated in the reversal of the sex ratio. Testosterone is an immunosuppressant and is likely to be protective, while female sex steroids are proinflammatory and will increase the susceptibility to atopy. Modified so as to be non-virilising/feminising, sex steroids could therefore play a useful part in modulating the immunological and inflammatory processes that underlie asthma and other allergic disorders, complementing the currently used glucocorticoid derived steroids.",
    keywords = "SYSTEMIC LUPUS-ERYTHEMATOSUS, PEAK FLOW VARIABILITY, MENSTRUAL-CYCLE, IMMUNE-SYSTEM, RESPIRATORY SYMPTOMS, RHEUMATOID-ARTHRITIS, GENDER DIFFERENCES, RISK-FACTORS, LUNG GROWTH, T-CELLS",
    author = "Mustafa Osman",
    year = "2003",
    doi = "10.1136/adc.88.7.587",
    language = "English",
    volume = "88",
    pages = "587--590",
    journal = "Archives of Disease in Childhood",
    issn = "0003-9888",
    publisher = "BMJ Publishing Group",
    number = "7",

    }

    TY - JOUR

    T1 - Therapeutic implications of sex differences in asthma and atopy

    AU - Osman, Mustafa

    PY - 2003

    Y1 - 2003

    N2 - Clear sex differences exist in asthma and atopy with a preponderance of boys before puberty. There is a reversal of this sex ratio during puberty with girls having more asthma and atopy throughout the reproductive years. Elucidating the reasons for the switch in the sex ratio should provide fresh insights into asthma and atopy with a real prospect of novel therapies for these troublesome diseases. The challenge is to match the epidemiology and physiology with the accumulating scientific knowledge on gender differences in immune responses. Hormonal changes have been implicated in the reversal of the sex ratio. Testosterone is an immunosuppressant and is likely to be protective, while female sex steroids are proinflammatory and will increase the susceptibility to atopy. Modified so as to be non-virilising/feminising, sex steroids could therefore play a useful part in modulating the immunological and inflammatory processes that underlie asthma and other allergic disorders, complementing the currently used glucocorticoid derived steroids.

    AB - Clear sex differences exist in asthma and atopy with a preponderance of boys before puberty. There is a reversal of this sex ratio during puberty with girls having more asthma and atopy throughout the reproductive years. Elucidating the reasons for the switch in the sex ratio should provide fresh insights into asthma and atopy with a real prospect of novel therapies for these troublesome diseases. The challenge is to match the epidemiology and physiology with the accumulating scientific knowledge on gender differences in immune responses. Hormonal changes have been implicated in the reversal of the sex ratio. Testosterone is an immunosuppressant and is likely to be protective, while female sex steroids are proinflammatory and will increase the susceptibility to atopy. Modified so as to be non-virilising/feminising, sex steroids could therefore play a useful part in modulating the immunological and inflammatory processes that underlie asthma and other allergic disorders, complementing the currently used glucocorticoid derived steroids.

    KW - SYSTEMIC LUPUS-ERYTHEMATOSUS

    KW - PEAK FLOW VARIABILITY

    KW - MENSTRUAL-CYCLE

    KW - IMMUNE-SYSTEM

    KW - RESPIRATORY SYMPTOMS

    KW - RHEUMATOID-ARTHRITIS

    KW - GENDER DIFFERENCES

    KW - RISK-FACTORS

    KW - LUNG GROWTH

    KW - T-CELLS

    U2 - 10.1136/adc.88.7.587

    DO - 10.1136/adc.88.7.587

    M3 - Article

    VL - 88

    SP - 587

    EP - 590

    JO - Archives of Disease in Childhood

    JF - Archives of Disease in Childhood

    SN - 0003-9888

    IS - 7

    ER -